It would be more like $11+ billion because there a
Post# of 148238
But the average clinical-stage buyout premium to the 30 day average share price has stayed steady over the years at around 100% with rare cases around 200% and very, very, very rare cases higher.
https://www.evaluate.com/vantage/articles/ins...hole-story